Eosinophilic esophagitis in the era of biologics.

Carlo Maria RossiGiovanni SantacroceMarco Vincenzo LentiAntonio di Sabatino

Published in: Expert review of gastroenterology & hepatology (2024)

Dupilumab has been the first approved biologic drug for the treatment of EoE; long-term studies assessing how it could change the natural history of EoE are awaited. Novel biological drugs or other molecules are currently under study and could change the current treatment algorithms in the near future. Proper drug positioning and long-term 'exit strategies' are yet to be defined.

Keyphrases

machine learning
rheumatoid arthritis
emergency department
combination therapy
drug induced
current status
replacement therapy